Yoganand Kumar D.

Yoganand Kumar D. is currently a Manager and Team Leader in the Clinical and HEOR Publications team at Eli Lilly and Company, where they lead efforts supporting neuroscience and oncology publication writers globally. Previously, they served as a Senior Group Leader overseeing late phase protocol teams and contributed significantly to regulatory submissions for the incretin portfolio. Yoganand's extensive experience in medical writing and clinical research spans various roles at organizations such as AXIS Clinicals Ltd and Cactus Communications. They hold a Master's in Pharmacy and an Executive MBA from IIM-V while actively championing Diversity, Equity, and Inclusion initiatives.